HCV protease inhibitor VX-950, Purity ≥98%

Cat. No.: X24-06-ZQ907

HCV protease inhibitor VX-950, Purity ≥98%

Synonym: 402957-28-2; HCV protease inhibitor; VX950; Incivek; Incivo

  • MDL: MFCD11616089
  • CAS Number: 402957-28-2
  • Compound CID: 3010818
Product Size
2 mg; 5 mg; 10 mg; 25 mg
Price
Datasheet
MSDS
Properties
Description
VX-950, soluble in DMSO and insoluble in ethanol and water, targets and inhibits the function of the hepatitis C virus protease enzyme. It targets HCV NS3-4A serine protease.
Molecular Weight
679.9
Molecular Formula
C36H53N7O6
Targets
HCV NS3-4A serine protease: 0.35 μM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 131 mg/mL (192.69 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
VX-950 targets HCV NS3/4A protease, aiding research in Hepatitis C treatment.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0